IL-33/ST2

Xiaolan Pan1, Jinfeng Liu1, Meiqin Li1

  • 1Department of Clinical Laboratory, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, China.

BMC cancer
|July 28, 2023
PubMed
概括

在肝细胞癌 (HCC) 患者中,介素-33 (IL-33) 和ST2水平升高. 高IL-33表达与晚期癌症和较差的存活率相关,表明IL-33/ST2作为预后生物标志物.